GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

People living in rural areas are at greater risk for obesity than the general population, and they often have limited access ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...

Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while ...

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...